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HIV, Hepatitis C, TB, Harm Reduction, and 
Persons Deprived of Liberty: What Standards Does 
International Human Rights Law Establish? 
gen sander and rick lines
Abstract 
HIV, hepatitis C virus (HCV), and TB in prisons and other places of detention are serious public health 
concerns, with prevalence and incidence considerably higher than in the general community because 
of the overrepresentation of risky behavior, substandard conditions, overcrowding, people who inject 
drugs, and the wholly inadequate prevention, care, and treatment of these conditions, including the 
denial of harm reduction services. This is not only a severe public health crisis but also a serious human 
rights concern. This article works to clarify the standards established by human rights law with regards 
to HIV, HCV, TB, and harm reduction in prisons by examining international and regional case law, 
minimum standards on the treatment of prisoners and public health, as well as the work of UN treaty 
bodies, Special Rapporteurs, and prison monitoring bodies. It is imperative that urgent steps are taken 
to close the gap between human rights and public health standards on the one hand, and effective 
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Background
HIV, hepatitis C virus (HCV), and tuberculosis 
(TB) epidemics are a major public health concern 
around the world. Although all affect the population 
at large, they have emerged as an especially severe 
problem in prisons and other places of detention 
worldwide. Prison populations have a significantly 
higher prevalence, and in some contexts a higher 
incidence, of these diseases than the general public. 
A recent review of the global epidemiology of HIV, 
HCV, and TB in prisoners estimated that, of the 
roughly 10 million people detained worldwide on 
any given day, 3.8% are living with HIV, 15.1% with 
HCV, and 2.8% with active TB.1 Throughout this 
article, the terms ‘prison,’ ‘detention’ and ‘closed 
settings’ are used interchangeably to refer to all 
places where people are deprived of their liberty. 
Similarly, the term ‘prisoner,’ ‘detainee’ and ‘people 
deprived of their liberty’ are used interchangeably 
to refer to all persons deprived of their liberty.
Prison settings represent high-risk environ-
ments for the transmission of these diseases for a 
number of reasons. For one, poor and marginal-
ized communities are overrepresented in prison 
populations worldwide.2 Many of the factors that 
contribute to disproportionate levels of incar-
ceration, such as poverty, discrimination, and 
criminalization of drug use and possession, also 
put these populations at increased vulnerability 
to similarly disproportionate rates of HIV, HCV, 
and TB. For example, people who inject drugs are 
24 times more likely to acquire HIV than the rest 
of the adult population, while HCV and TB preva-
lence are also much higher among this population.3 
Punitive approaches to drug use have re-
sulted in the mass incarceration of people who 
use drugs. Currently, around one in every five 
prisoners is serving time for a drug offense, and 
it has been estimated that 56-90% of people who 
inject drugs will be incarcerated at some stage 
of their lives.4 Despite the secure and allegedly 
drug-free nature of closed custody settings, many 
people continue to use drugs on an occasional or 
regular basis while in detention. Injecting drug 
use is common in prisons in every region of the 
world, and sharing of injecting equipment—some-
times with 15-20 people—occurs out of necessity.5 
Intensifying this risk of infection and related ill 
health are the substandard conditions in which 
detainees are frequently held. Overcrowding, poor 
sanitation, inadequate ventilation and means for 
maintaining personal hygiene, and lack of access 
to clean drinking water and nutritional food are 
common in prisons and contribute to high rates of 
disease and death. These poor conditions invari-
ably exist within a climate of violence, humiliation, 
and discrimination that creates barriers to access-
ing health care services, which are often weak or 
inadequate to begin with. 
Despite this reality, the provision of HIV, HCV, 
and TB treatment and prevention programs, includ-
ing evidence-based harm reduction services such 
as needle and syringe programs (NSPs) and opioid 
substitution therapy (OST), remain extremely lim-
ited in prisons in comparison to what is available in 
the broader community.  Currently, while 90 coun-
tries implement NSPs in the broader community, 
only eight make the service available in at least one 
prison. At the same time, while 80 countries provide 
OST in the broader community, only 52 provide the 
service in at least one prison, and only 43 countries 
provide HIV treatment in prisons.6 
Ill health and poor conditions in prisons do 
not only concern prisoners and prison staff; they 
are issues of much wider public health concern. 
Around one-third of people incarcerated world-
wide return to their communities every year, and 
because recidivism is common, especially among 
people who use drugs, there is a high degree of 
mobility between prison and community.7 Prison 
health, therefore, is intimately connected to public 
health.8 This is not just a public health concern, 
however, but also a human rights imperative. 
Human rights, health, and persons 
deprived of liberty
Under international human rights law, persons de-
prived of their liberty retain all fundamental rights 
and freedoms, apart from those that are unavoid-
ably restricted by the fact of their incarceration.9 
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Like all persons, therefore, detainees have a right 
to health. 
The cornerstone protection of the right to 
health in international law is found in Article 12 of 
the International Covenant on Economic, Social 
and Cultural Rights (ICESCR), but several pro-
visions found in a range of other widely ratified 
international and regional human rights treaties 
also protect prisoners’ health rights.10 Some of these 
specifically articulate the right to health, while 
others, such as the prohibition of torture and ill 
treatment, for example, offer indirect protection. 
The prohibition of torture and ill treatment im-
poses positive obligations on states to protect the 
lives and/or well-being of persons deprived of lib-
erty, which has been interpreted by several human 
rights mechanisms to require government author-
ities to safeguard the health of prisoners.11 As will 
be demonstrated, the right to health and freedom 
from torture and ill treatment are indivisible and 
interdependent, particularly in closed settings.12
The highly generalized language used to ar-
ticulate health rights in human rights treaties does 
not shed much light on the specific entitlements 
and obligations to which they give rise. UN treaty 
bodies, however, have provided useful operational 
guidance in their work to help understand the con-
tours and content of particular rights. According 
to the UN Committee on Economic, Social and 
Cultural Rights (CESCR), for example, the right to 
health is not a right to be healthy; rather, it is an 
inclusive right that extends not only to timely and 
appropriate medical care, but also to the underlying 
determinants of health, such as access to adequate 
sanitation facilities, healthy environmental condi-
tions, essential drugs, and health-related education 
and information.13 This broad understanding of the 
right to health is important in the context of places 
of detention. 
Clarifying the normative content of detainees’ 
right to health entitlements, and the obligations 
that these impose on state authorities, requires an 
examination of international and regional treaty 
and case law, minimum standards on the treatment 
of prisoners and public health more generally, 
as well as the work of UN treaty bodies, Special 
Rapporteurs, and prison monitoring bodies. The 
following sections rely on these sources to identify 
some of the most relevant entitlements and obliga-
tions that stem from the right to health of prisoners 
in the context of HIV, HCV, TB, and harm reduc-
tion. Before turning to that, however, a brief word 
on standards will be helpful. Some standards, such 
as the absolute ban on torture and ill treatment and 
the obligation to respect the right to health by re-
fraining from denying or limiting equal access for 
all persons to health services, are protected by in-
ternational and regional treaties, as well as national 
constitutions and laws. Other public health and hu-
man rights standards, such as those included in the 
UN Standard Minimum Rules for the Treatment of 
Prisoners, codify much more specific entitlements 
and obligations with regards to, for example, ade-
quate medical care for persons in detention. While 
the latter do not formally enjoy the status of inter-
national law, and are technically non-binding “soft 
law” instruments, a strong argument can be made 
that they have become accepted minimum legal 
requirements for governments to meet.14 
A right to non-discrimination and equivalence 
of care
Like with many other socioeconomic rights, the 
right to health is subject to both resource availability 
and progressive realization. Yet regardless of their 
economic situation, states must fulfill minimum 
core obligations with respect to health, including 
to prisoners. One of these core obligations, which 
is both of immediate effect and non-derogable, is 
to “ensure the right of access to health facilities, 
goods and services, on a non-discriminatory 
basis, especially for vulnerable and marginalised 
groups.”15 Detained against their will, prisoners are 
at the mercy of the prison authorities, which puts 
them in a uniquely vulnerable position. Effectively 
deprived of the ability to provide for themselves, it 
has been argued that state actors have heightened 
obligations vis-à-vis prisoners.16 This is reflected in 
the CESCR’s General Comment 14.17
In the context of harm reduction in prisons, 
the former UN Special Rapporteur on the right 
to health has stated that “If harm reduction pro-
g. sander and r. lines  / papers, 171-182
174
D E C E M B E R  2 0 1 6    V O L U M E  1 8    N U M B E R  2   Health and Human Rights Journal
grammes and evidenced-based treatment are made 
available to the general public, but not to persons 
in detention, that contravenes international law.”18 
Indeed, the importance of ensuring non-dis-
criminatory access to health facilities, goods, and 
services in prisons has been widely endorsed in hu-
man rights and public health standards, guidelines, 
and other documents. Several standards of humane 
treatment of prisoners make reference to non-dis-
crimination in accessing health care, including the 
European Prison Rules, the UN Basic Principles 
for the Treatment of Prisoners, and the revised UN 
Standard Minimum Rules for the Treatment of 
Prisoners, which state that “Prisoners should enjoy 
the same standards of health care that are avail-
able in the community, and should have access to 
necessary health-care services free of charge with-
out discrimination on the grounds of their legal 
status.”19 It is also reflected in many international 
declarations and guidelines, including in the World 
Health Organization’s (WHO) 1993 Guidelines on 
HIV infection and AIDS in prisons, and various 
other UN documents and statements.20 
Very closely related to the obligation of 
non-discrimination is the principle of equivalence: 
the obligation to provide a standard of care that is at 
least equivalent to that available in the community. 
It is worth mentioning that despite the principle 
of equivalence enjoying broad consensus among 
international health and human rights authorities, 
including UN bodies, the European Union and 
the European Committee for the Prevention of 
Torture and Inhuman or Degrading Treatment or 
punishment (CPT), it has one notable detractor: 
the European Court of Human Rights. In Gladkiy 
v. Russia, the Court stated that it “does not always 
adhere to this standard, at least when it comes to 
medical assistance to convicted prisoners” and 
that “[freedom from inhuman or degrading treat-
ment] cannot be interpreted as securing for every 
detained person medical assistance at the same 
level as in ‘the best civilian clinics.’”21 While this 
position flies in the face of well-established inter-
national consensus, it is not very surprising given 
the Court’s practice of deferring to the judgment 
of national authorities, also known as its “margin 
of appreciation doctrine.”22 The former Special Rap-
porteur on the right to health has clearly stated that 
“in the context of HIV and harm reduction, this 
demands implementation of harm reduction ser-
vices in places of detention even where they are not 
yet available in the community, as the principle of 
equivalence is insufficient to address the epidemic 
among prisoners.”23 
A right to essential medicines
Another important core obligation vis-à-vis pris-
oners’ right to health, which is also non-derogable 
and of immediate effect, is to provide essential 
medicines as defined by WHO’s Essential Medi-
cines Programme.24 According to the latest WHO 
definition, essential medicines are “those that 
satisfy the priority health-care needs of the popu-
lation” and are “selected with due regard to disease 
prevalence, evidence of efficacy and safety and 
comparative cost-effectiveness.”25 They are meant 
to be available at all times in adequate amounts, in 
the appropriate dosage forms, with assured quality, 
and at an affordable price.26 
WHO’s Model List of Essential Medicines in-
cludes morphine, methadone, and buprenorphine, 
drugs commonly used to treat opioid dependence.27 
Because these are classified as “controlled substanc-
es” under the international drug conventions, their 
availability is often limited. Where these essential 
medicines are available in the community, they are 
often of poorer quality, not provided on a continu-
ous basis, or simply unavailable in closed settings.28 
For example, while 80 countries and territories 
implement OST in the broader community, only 52 
countries provide the service in at least one pris-
on.29 There are several reasons for this, including 
the common perception that prisons should be 
“drug-free zones,” unfounded concerns about the 
provision of OST leading to diversion of medica-
tion, violence, and/or security breaches, as well 
as a preference for abstinence-based treatment.30 
Unfortunately, these misconceptions continue to 
overshadow unequivocal scientific evidence re-
vealing OST to be the most effective treatment in 
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managing opioid dependence, preventing HIV and 
HCV transmission, and in caring for drug users 
living with HIV or other infections.31 
Again, the obligation to provide essential 
medicines should be discharged on a non-dis-
criminatory basis, as the Human Rights Council 
highlighted when it recognized the “responsibility 
of States to ensure access to all, without discrimina-
tion, of medicines, in particular essential medicines, 
that are affordable and of good quality.”32 From a 
public health and human rights perspective, it is 
imperative that essential medicines be equally ac-
cessible in places of detention. The former Special 
Rapporteur on the right to health has called on 
states to “ensure that all harm reduction measures 
and drug dependence treatment services, partic-
ularly opioid substitution therapy, are available to 
people who use drugs, in particular those among 
incarcerated populations.”33 
The right to essential medicines also engages 
the right to humane treatment. The UN Special 
Rapporteur on torture recently explained that 
when “the failure of States to take positive steps, 
or to refrain from interfering with health-care 
services, condemns patients to unnecessary suf-
fering from pain, States not only fall foul of the 
right to health, but may also violate an affirmative 
obligation under the prohibition of torture and ill 
treatment.”34 The UN Human Rights Committee 
also recently confirmed that “physical and mental 
pain and suffering associated with withdrawal 
symptoms may amount to torture or ill treatment,” 
and that states have an obligation to ensure that 
drug users deprived of their liberty are effectively 
protected against this pain and suffering through 
the provision of timely, adequate and scientifically 
based medical assistance.35 
A right to medical care and treatment
The right to medical care and treatment is a criti-
cally important element of the right to health and 
like all other rights, it belongs to everyone, includ-
ing prisoners. CESCR has explicitly affirmed that 
“States are under the obligation to respect the right 
to health by…refraining from denying of limiting 
equal access for all persons, including prisoners or 
detainees … [to] curative and palliative health ser-
vices.”36 On a number of occasions, when reviewing 
the implementation of state obligations, CESCR 
has expressed a specific concern about inadequate 
access to health care in prisons and has explained 
that medical care and treatment must not only be 
accessible, but also “timely and appropriate.”37
This obligation is also expressed regularly 
within civil and political rights mechanisms. The 
UN Human Rights Committee, for example, has 
affirmed that the obligation to “provide appropriate 
medical care to detainees” is engaged under Article 
10 (prohibition of inhuman and degrading treat-
ment) of the International Covenant on Civil and 
Political Rights.38 The former Special Rapporteur 
on torture has also stated that “denial of medical 
treatment and/or absence of access to medical care 
in custodial situations may constitute cruel, inhu-
man or degrading treatment or punishment and is 
therefore prohibited under international human 
rights law.”39
The European Court of Human Rights has 
also recognized the obligation to provide care and 
treatment specifically for communicable diseases in 
prisons. In Gladkiy v. Russia, the Court held that “the 
State does have a responsibility to ensure treatment 
for prisoners in its charge” and that “[a]bsent or inad-
equate treatment for tuberculosis, particularly when 
the disease has been contracted in detention, is most 
certainly subject of the Court’s concern.”40 Providing 
guidance on what “adequate” means, the Court has 
stated that “The mere fact that a detainee was seen by 
a doctor and prescribed a certain form of treatment 
cannot automatically lead to the conclusion that the 
medical assistance was adequate.”41
On several occasions, the Court has found 
that inadequate care and treatment for HIV, HCV, 
and/or TB has amounted to cruel, inhuman, or 
degrading treatment.42 In Khudobin v. Russia, the 
Court found that in the given context, the absence 
of medical assistance for a prisoner living with HIV 
amounted to degrading treatment.43 In Koryak v. 
Russia and A.B. v. Russia, the fact that detainees did 
not receive comprehensive, effective, transparent, 
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or timely medical assistance for HIV and TB was 
sufficient for the Court to find that the authorities 
had failed to comply with their responsibility to 
ensure the provision of adequate medical treat-
ment, which amounted to inhuman and degrading 
treatment.44 In Kozhokar v. Russia, the Court found 
that the applicant did not receive comprehensive, 
effective, and regular medical assistance for HIV 
or HCV during detention, which amounted to de-
grading treatment.”45 
The Court has also found that inadequate 
treatment of drug dependence violates the prohibi-
tion of cruel, inhuman, or degrading treatment. In 
a very recent case, Wenner v. Germany, the Court 
established that “the refusal to provide the appli-
cant with drug substitution treatment despite his 
manifest opioid addiction caused him considerable 
and continuous mental suffering for a long time.”46 
The Court concluded that Germany’s failure to 
provide “comprehensive and adequate medical care 
in detention, at a level comparable to that which 
the State authorities have committed themselves to 
provide to persons in freedom, where drug substi-
tution was available,” amounted to cruel, inhuman, 
and degrading treatment.47 In another especially 
notable case, McGlinchey and Others v. UK, the 
Court held that the failure of prison health facili-
ties to provide adequate medical care to a prisoner 
undergoing heroin withdrawal, who subsequently 
died, constituted ill treatment.48 Specifically, the 
Court found that the prisoner’s suffering derived 
not from heroin withdrawal but “the failure of 
prison authorities to take more effective steps to 
combat her withdrawal symptoms and [that her] 
deteriorating condition must have contributed to 
her pain and distress.”49 International and regional 
standards relating to the treatment of prisoners re-
flect this obligation to provide adequate health care 
and treatment. The Standard Minimum Rules for 
the Treatment of Prisoners, for example, explicitly 
state that “the provision of health care for prisoners 
is a State responsibility,” which is reiterated in the 
European Prison Rules.50 
An important element of the right to health 
care and treatment in the context of places of de-
tention is that of continuity of care and treatment. 
People with health issues who move between deten-
tion and the community can find short periods in 
prison very disruptive to their community-based 
care and treatment programs. Others who start a 
particular treatment in prison often do not get con-
nected with appropriate aftercare following release, 
a concern highlighted by WHO, the UN Office on 
Drugs and Crime (UNODC), and the Joint United 
Nations Programme on HIV/AIDS (UNAIDS).51 
This important obligation is also explicitly artic-
ulated in the revised Standard Minimum Rules 
for the Treatment of Prisoners. Rule 24(2) states: 
“Health-care services should be organised in close 
relationship to the general public health admin-
istration and in a way that ensures continuity of 
treatment and care, including for HIV, tuberculosis 
and other infectious diseases, as well as for drug 
dependence.”52 Several public health standards also 
reiterate this important principle.53 
A right to preventive health services, including 
harm reduction
Particularly relevant to the context of HIV, HCV, 
and TB in prisons is the right to preventive health 
services. In recognition of this, CESCR has iden-
tified the obligation to take measures to prevent, 
treat, and control diseases as being of comparable 
priority to the core obligations under the right to 
health.54 It specifically identifies prisoners and 
detainees as being entitled to this fundamental 
right, confirming: “States are under the obligation 
to respect the right to health by…refraining from 
denying or limiting equal access for all persons, 
including prisoners or detainees…to preventive…
health services.”55 More specifically, CESCR has on 
more than one occasion recommended that states 
take steps to combat infections within prisons, par-
ticularly the most severe, such as TB and HIV.56 The 
Special Rapporteur on torture has also explicitly 
stated that “states have an obligation to ensure that 
drug dependence treatment as well as HIV/hepati-
tis C prevention and treatment are accessible in all 
places of detention,” and that “needle and syringe 
programmes should be used to reduce the risk of 
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infection with HIV/AIDS.”57
The obligation is also confirmed in interna-
tional and regional jurisprudence. For example, the 
UN Human Rights Committee, in its Concluding 
Observations on Moldova, noted that “Danger to 
the health and life of detainees as a result of the 
spread of contagious diseases and inadequate care 
amounts to a violation of article 10 [prohibition of 
torture and ill treatment]…and may also include a 
violation of articles 9 [right to liberty and security 
of the person] and 6 [right to life].”58 The European 
Court of Human Rights has sustained this view in 
a number of its judgments. In Melnik v. Ukraine, 
the Court found a violation of the prohibition of 
ill treatment, in part, for the failure to prevent the 
applicant’s tuberculosis while he was in prison.59 
In Staykov v. Bulgaria, the Court found the fact 
that ‘‘the applicant fell ill with tuberculosis’’ while 
in prison, along with a finding that ‘‘the prison 
authorities’ prevention efforts were inadequate’’ 
among the factors contributing to a violation of the 
prohibition of ill treatment.60 
This legally binding obligation is also reflect-
ed in several prison health standards, WHO and 
World Medical Association declarations, as well as 
non-binding resolutions of the Council of Europe 
and Parliamentary Assembly.61 The CPT has also con-
firmed that “the act of depriving a person of his liberty 
always entails a duty of care which calls for effective 
methods of prevention, screening, and treatment.”62 
There is unequivocal evidence that the most 
effective way to prevent HIV and HCV infection 
within prisons is through the provision of harm 
reduction services.63 This has been endorsed by a 
number of human rights and public health author-
ities. CESCR, for example, expressed concern at the 
rapid transmission of HIV in Tajikistan and Mau-
ritius, in particular among prisoners, sex workers, 
and people who use drugs.64 The Committee spe-
cifically called upon the government of Tajikistan 
to “establish time-bound targets for extending 
the provision of free...harm reduction services to 
all parts of the country” and to implement needle 
and syringe programs and OST based on inter-
national best practice standards in prisons.65 In a 
2009 statement, the UN High Commissioner for 
Human Rights recognized “the longstanding evi-
dence that a harm reduction approach is the most 
effective way of protecting rights, limiting personal 
suffering, and reducing the incidence of HIV,” and 
stressed that “this is particularly the case for those in 
detention, who are already vulnerable to many forms 
of human rights violations.”66 Furthermore, the Ma-
drid recommendation: Health protection in prisons 
as an essential part of public health, which was en-
dorsed by representatives from 65 countries as well 
as the WHO, UNODC, and the Council of Europe, 
among many others, recognizes “the urgent need in 
all prison systems for measures, programmes and 
guidelines which are aimed at preventing and con-
trolling major communicable diseases in prisons,” 
including “harm reduction measures, including 
opioid substitution therapy, needle and syringe ex-
change…and condom distribution.”67 
It is important to briefly mention that human 
rights and public health standards, as well as min-
imum standards on the treatment of prisoners, 
require that testing and treatment, particularly for 
HIV and drug dependence, be voluntary and car-
ried out only with the free and informed consent 
of the prisoner.68 As the Special Rapporteurs on 
the right to health and torture have both affirmed, 
“Guaranteeing informed consent is a fundamental 
feature of respecting an individual’s autonomy, 
self-determination and human dignity.”69 In the 
same breath, confidentiality must be protected, 
particularly in prison settings where the risk of 
reprisal is high, and information on health status 
must not be disclosed to third parties without the 
consent of the prisoner.70 
A right to the underlying determinants of health
As already mentioned, the right to health extends 
not only to health care but also to the underlying 
determinants of health, which have a considerable 
impact on whether people are healthy or not. This 
is particularly relevant in the context of prisons 
and other places of detention, where overcrowding, 
inadequate sanitary facilities, poor hygiene, poor 
nutrition, and inadequate access to drinking water 
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are often the rule rather than the exception. As 
conditions of detention are integrally linked to the 
health status of those held within them, it is no won-
der that conditions under which detainees are held 
have been found to favor the spread of diseases.71
CESCR has identified housing as “the envi-
ronmental factor most frequently associated with 
conditions for disease” and notes that “inadequate 
and deficient housing and living conditions are 
invariably associated with higher mortality and 
morbidity rates.”72 The Standard Minimum Rules 
for the Treatment of Prisoners also recognize that 
the failure to provide, among other things, ade-
quate space, lighting, ventilation, nutritious food, 
drinking water, and appropriate hygiene and san-
itary installations can be detrimental to the health 
of persons in detention.73 
The Committee Against Torture and the 
Special Rapporteur on torture have also found that 
inadequate conditions of detention could amount 
to ill treatment.74 Similarly, the European Court of 
Human Rights has found that health decline, or 
the contracting of disease, while in detention may 
also be judged as evidence that the overall prison 
conditions are inhuman or degrading.75  
A right to participation 
The right to participation, the basic right of people 
to have a say in matters that affect their lives, has 
been described as the right of all rights.76 While 
the essential role of participation in realizing 
fundamental human rights has been explicitly rec-
ognized in all legally binding human rights treaties, 
it is particularly important in realizing the right to 
health. CESCR and the former Special Rapporteur 
on the right to health have identified participation 
in all health-related decision-making as an im-
portant component of the right to health, as well 
as one of the underlying determinants of health.77 
One of the core obligations of the right to health is 
the provision for participation in the development, 
implementation, and review of the national health 
plan that focuses on issues affecting the most vul-
nerable and marginalized, as well as in the health 
policies and interventions flowing from that plan.78 
In reality, it may not be possible to ensure every-
one’s participation, but the government has an 
immediate obligation to obtain a representation of 
views, particularly of those most vulnerable and 
marginalized.
Importantly, individuals have a right to “ac-
tive and informed” participation, which relies on 
institutional arrangements and specific mecha-
nisms to ensure participation at different stages, as 
well as capacity-building activities to ensure that 
people have the ability to participate meaningfully 
and effectively.79 In this context, it is important to 
note that informed participation relies on the right 
to health-related education and information. 
A human rights-based approach to health 
(HRBA) requires that prisoners participate in the 
entire process of prison-based HIV, HCV, TB, 
and harm reduction programming, from identi-
fying priorities, to designing and implementing 
programmes, to monitoring and evaluating their 
impact and effectiveness. Considerable benefits to 
people’s participation in health decisions have been 
identified, including increased sustainability and 
effectiveness of interventions, improvements in the 
quality of health care and services, empowerment 
of individuals, enhanced accountability, and posi-
tive health and health-related outcomes.80 
WHO, UNODC, and UNAIDS have recog-
nized the importance of prisoner participation in 
the context of the development and implementation 
of policies and initiatives to address HIV in prisons.81 
There is also recognition of the value of the partici-
pation of detainees at the European level. In January 
2006, the Committee of Ministers of the Council of 
Europe adopted Recommendation (2006) 2, which 
contains the revised European Prison Rules. A new 
Rule 50 requires that prisoners be allowed and en-
couraged to discuss matters relating to the general 
conditions of imprisonment with prison adminis-
trations. The commentary to the recommendation 
states that “it is in the interests of prisoners as a 
whole that prisons should run smoothly and they 
may well have suggestions to make.”82 The CPT has 
also suggested that prisoners’ own evaluations of 
existing health care services might represent one 
element in determining necessary changes to health 
care systems for the prison population.83  
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Conclusion
The right to health and the right to be free from 
ill treatment are increasingly recognized as being 
interrelated and indivisible, especially in prison 
contexts, by UN bodies and mechanisms, courts, 
and prison monitoring bodies. Indeed, as the for-
mer Special Rapporteur on the right to health has 
noted, “The promotion and protection of the right 
to health…strengthens the prevention of torture 
and ill-treatment, while the prohibition of torture…
reinforces the realisation of the right to health.”84 
People retain their human rights during 
incarceration, including their right to the highest 
attainable standard of health. There is an enormous 
gap, however, between public health and human 
rights standards on the one hand, and effective im-
plementation in custody settings on the other. Data 
revealing the high prevalence rates inside places 
of detention compared to those in the broader 
community, for example, demonstrate that this is 
particularly the case with regards to HIV, HCV, and 
TB. Despite their vulnerability to ill health, persons 
deprived of liberty are much less likely to have ac-
cess to adequate prevention, care, and treatment of 
these diseases, including harm reduction services. 
Additionally, they are often held in substandard 
conditions that favor the transmission of diseases. 
This clearly creates an imperative for increased and 
ongoing attention to HIV, HCV, and TB in places of 
detention, including a focus on the urgent need to 
scale up harm reduction in these settings.
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